Clinical Trials Directory

Trials / Conditions / Recurrent Childhood Liver Cancer

Recurrent Childhood Liver Cancer

8 registered clinical trials studyying Recurrent Childhood Liver Cancer.

StatusTrialSponsorPhase
WithdrawnImetelstat Sodium in Treating Younger Patients With Relapsed or Refractory Solid Tumors
NCT02011126
Children's Oncology GroupPhase 2
CompletedTrametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder
NCT02042443
National Cancer Institute (NCI)Phase 2
CompletedSorafenib Tosylate in Treating Younger Patients With Relapsed or Refractory Rhabdomyosarcoma, Wilms Tumor, Liv
NCT01502410
National Cancer Institute (NCI)Phase 2
CompletedCixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors
NCT00831844
National Cancer Institute (NCI)Phase 2
CompletedOxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas
NCT00101270
National Cancer Institute (NCI)Phase 1
CompletedOxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatme
NCT00091182
National Cancer Institute (NCI)Phase 2
CompletedFlavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or Lymphomas
NCT00012181
National Cancer Institute (NCI)Phase 1
CompletedCombination Chemotherapy With or Without Amifostine in Treating Young Patients With Liver Cancer
NCT00003994
Children's Oncology GroupPhase 3